Intec Pharma Announces Pricing of $35.4 Million Public Offering of Ordinary Shares

Intec Pharma Ltd. (NASDAQ and TASE: NTEC) today announced the pricing of an underwritten public offering of 6.75 million of its ordinary shares at a public offering price of $5.25per ordinary share. The gross proceeds of the offering are expected to be approximately $35.4 million, before deducting underwriting discounts and commissions and other estimated offering expenses.